Physician profile
Joel E Rand
NPI 1629140041
$3,609.86
in general payments reported to CMS, 2019-2025
12 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,321 · 2022: $581 · 2023: $315 · 2024: $228 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,541.99 | 2021-2024 | Da Vinci Surgical System |
| Medtronic, INC. | $349.33 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $182.54 | 2024-2025 | |
| Becton, Dickinson and Company | $135.26 | 2024 | Phasix Mesh |
| Ethicon US, LLC | $121.62 | 2022 | |
| Stryker Corporation | $80.50 | 2021 | |
| Heron Therapeutics, INC. | $61.14 | 2023 | Aponvie |
| Acacia Pharma INC | $40.88 | 2021 | |
| Conmed Corporation | $35.71 | 2024 | Conmed Specimen Retrieval, Conmed Pads and Pencils, Airseal |
| Medical Device Business Services, INC. | $27.84 | 2024 | Echelon Flex |
| Endo Pharmaceuticals INC. | $21.15 | 2021 | |
| Baxter Healthcare | $11.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Rand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.